RAAS Inhibitors and Statins in COVID-19 Pandemic -A Perspective

Abstract

Novel Corona virus (COVID-19) caused global outbreak and affected the health of many individuals and caused millions of death worldwide. World health organisation announced this disease as pandemic virus. This disease was first reported in Hubei Province on December at Wuhan, China. Within a short span the disease spread across 177 countries across the globe and World health organisation reported 16,755,633 confirmed cases and 661244 deaths as on 29th July 2020. Respiratory illness and mild flu like symptoms are mostly common symptoms of COVID-19. It also affects the cardiovascular status especially the individual with pre-existing cardiovascular disease. Direct myocardial injury is observed and appearance of inflammation is the primary mechanism involved for Cardiac injury. This review enlightens the role of RAAS Inhibitors like ACE-Is, ARBs and statins in COVID-19 pandemic.